Evidence map›Paper›PMID 34660627›Full record

ReviewFrontiers in medicine2021

Qiuyue Huang, Xiaofen Jia, Yingming Chu, Xuezhi Zhang, Hui Ye

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Effect of Probiotic-Assisted Eradication ofBioMed research international · 2022
    Trial
  3. Helicobacter pylori Management in Older Adults: Current Perspectives From Japan.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
  4. Trends in the burden and quality of care for upper gastrointestinal diseases from 1990 to 2021: An analysis of the global burden of disease study 2021.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
  5. Article
  6. Component-specific effects of PMFrontiers in public health · 2026
    Article
  7. Dyspepsia in nonagenarian women.European geriatric medicine · 2025
    Article
  8. Article
  9. The Aging Stomach: Clinical Implications ofInternational journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Focusing onFrontiers in cellular and infection microbiology · 2023
    Review
  14. Article
  15. Potential Active Constituents fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  16. Seroprevalence ofAccess microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiuyue HuangDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.
Xiaofen JiaDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.
Yingming ChuDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.
Xuezhi ZhangDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.
Hui YeDepartment of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

complementary therapydual therapyelderlyeradication therapyHelicobacter pyloristomach cancer

Identifiers

PMID34660627
PMCPMC8514670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.